ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.021,65
0,21%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. NeuroOne Medical Technologies Corporation (NMTC)

  7. NeuroOne Medical Technologies Corporation (NMTC) News

NMTC NeuroOne Medical Technologies Corporation

1,1899
-0,0201 (-1,66%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
NeuroOne Medical Technologies Corporation NMTC NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,0201 -1,66% 1,1899 01:19:56
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,23 1,15 1,231 1,17 1,21
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
10.4.202415:00GLOBENeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
09.4.202415:05GLOBENeuroOne® Announces First Implant of OneRF™ Ablation..
04.4.202415:00GLOBENeuroOne® CEO Dave Rosa Featured on Fox Business Network’s..
26.3.202414:00GLOBENeuroOne® Initiates Limited Commercial Launch of OneRF™..
08.3.202418:00GLOBENeuroOne® to Participate in the 36th Annual Roth Conference
04.3.202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202419:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202423:10GLOBENeuroOne Reports Inducement Grant Under Nasdaq Listing Rule..
21.2.202417:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202416:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202422:15EDGAR2Form 8-K - Current report
13.2.202422:00GLOBENeuroOne® Reports First Quarter Fiscal Year 2024 Financial..
08.2.202421:30GLOBENeuroOne® to Report First Quarter Fiscal Year 2024 Financial..
01.2.202419:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
29.1.202415:02EDGAR2Form ARS - Annual Report to Security Holders
29.1.202415:00EDGAR2Form DEF 14A - Other definitive proxy statements
05.1.202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03.1.202419:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.12.202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.12.202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.12.202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202315:35EDGAR2Form 144 - Report of proposed sale of securities
15.12.202322:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
15.12.202322:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14.12.202322:30EDGAR2Form 8-K - Current report
14.12.202322:15GLOBENeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year..
11.12.202314:15EDGAR2Form 8-K - Current report
11.12.202314:00GLOBENeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™..
07.12.202322:30GLOBENeuroOne® to Report Fourth Quarter and Fiscal Year 2023..
04.12.202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202322:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16.11.202314:00EDGAR2Form 8-K - Current report
16.11.202314:00GLOBENeuroOne® Announces Patent Allowance for Drug Delivery..
14.11.202323:15GLOBENeuroOne® Appoints Medtech Executive Christopher R. Volker..
14.11.202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202323:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.11.202314:15EDGAR2Form 8-K - Current report
07.11.202314:00GLOBENeuroOne® Provides Progress Update on FDA 510(k) Submission..

Kürzlich von Ihnen besucht

NASDAQ
NMTC
NeuroOne Medical Technol...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten